CompletedNCT01850355
Buspirone for Anxiety in Young People With Autism
About this title
Read the official source — NCT01850355Medication studyAges 6–17United States
Understand this study
Who was this study for?
This study was for people with anxiety. Listed age limits: 6 years to 17 years. Other eligibility criteria applied.
- Listed locations
- BostonSee all locations and recruitment
Study information
Study start dateStarted: July 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 9
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT01850355
- Official title
Show the full official title
An Open-label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Buspirone.
Who was this study for?
This study was for people with anxiety. Listed age limits: 6 years to 17 years. Other eligibility criteria applied.
